We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
(+18%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$101M |
| 2 |
Alcon
ALC
|
+$87.1M |
| 3 |
Otis Worldwide
OTIS
|
+$68.8M |
| 4 |
MRSH
Marsh
MRSH
|
+$50M |
| 5 |
Merck
MRK
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$56M |
| 2 |
JPMorgan Chase
JPM
|
+$42.7M |
| 3 |
Amazon
AMZN
|
+$38.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$36.5M |
| 5 |
Microsoft
MSFT
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.31% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFM
676
DELISTED
Sanderson Farms Inc
SAFM
| $2.31M | 0.01% |
19,931
-10,464
| -34% | -$1.34M |
|
677
AtriCure
ATRC
$2.13B
| $2.31M | 0.01% |
51,329
-67,097
| -57% | -$2.92M |
|
678
Match Group
MTCH
$8.56B
| $2.31M | 0.01% |
+21,545
| New | +$1.8M |
|
|
TPTX
679
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.31M | 0.01% |
35,707
-47,810
| -57% | -$2.76M |
|
|
BAND
680
Bandwidth Inc
BAND
$1.63B
| $2.31M | 0.01% |
18,150
-35,659
| -66% | -$3.6M |
|
|
CSW
681
CSW Industrials
CSW
$5.68B
| $2.31M | 0.01% |
33,346
-23,749
| -42% | -$1.6M |
|
|
BKI
682
DELISTED
Black Knight, Inc. Common Stock
BKI
| $2.31M | 0.01% |
31,765
-31,450
| -50% | -$2.23M |
|
683
Agios Pharmaceuticals
AGIO
$1.95B
| $2.3M | 0.01% |
+43,076
| New | +$1.99M |
|
684
Deckers Outdoor
DECK
$13.1B
| $2.3M | 0.01% |
70,392
-93,834
| -57% | -$2.59M |
|
685
NewMarket
NEU
$8.22B
| $2.3M | 0.01% |
5,753
-3,632
| -39% | -$1.5M |
|
686
United Therapeutics
UTHR
$23B
| $2.3M | 0.01% |
+19,040
| New | +$2.14M |
|
687
Chegg
CHGG
$100M
| $2.3M | 0.01% |
34,226
-64,581
| -65% | -$3.45M |
|
688
iRhythm Holdings
IRTC
$4.11B
| $2.3M | 0.01% |
19,864
-24,946
| -56% | -$2.75M |
|
689
Mercury Systems
MRCY
$6.57B
| $2.3M | 0.01% |
29,265
-22,379
| -43% | -$1.83M |
|
690
Acadia Pharmaceuticals
ACAD
$5.06B
| $2.3M | 0.01% |
+47,422
| New | +$2.28M |
|
691
Flowers Foods
FLO
$1.53B
| $2.3M | 0.01% |
102,831
-76,370
| -43% | -$1.72M |
|
692
Globus Medical
GMED
$11.3B
| $2.3M | 0.01% |
48,182
-38,775
| -45% | -$1.87M |
|
|
ATRI
693
DELISTED
Atrion Corp
ATRI
| $2.3M | 0.01% |
3,608
-2,079
| -37% | -$1.36M |
|
694
Varonis Systems
VRNS
$5.11B
| $2.3M | 0.01% |
77,883
-90,408
| -54% | -$2.26M |
|
|
BCPC
695
Balchem Corp
BCPC
$5.69B
| $2.3M | 0.01% |
24,211
-13,487
| -36% | -$1.26M |
|
|
AMED
696
DELISTED
Amedisys
AMED
| $2.3M | 0.01% |
11,565
-9,061
| -44% | -$1.69M |
|
|
WIRE
697
DELISTED
Encore Wire Corp
WIRE
| $2.3M | 0.01% |
47,021
-38,138
| -45% | -$1.75M |
|
698
SPS Commerce
SPSC
$2.67B
| $2.29M | 0.01% |
30,552
-50,485
| -62% | -$3.08M |
|
699
Corcept Therapeutics
CORT
$12.2B
| $2.29M | 0.01% |
136,349
-180,494
| -57% | -$2.54M |
|
700
LiveRamp
RAMP
$2.3B
| $2.29M | 0.01% |
53,992
-56,205
| -51% | -$2.21M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2020 Portfolio in Review
As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
- Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
- Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
- Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
- Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
- Aviva opened 49 new positions and closed 36 in Q2 2020.
- Aviva's portfolio value rose 18% quarter-over-quarter to $16B.
Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.